Found: 22
Select item for more details and to access through your institution.
Prostate-specific antigen testing rates remain low in UK general practice: a cross-sectional study in six English cities.
- Published in:
- BJU International, 2011, v. 108, n. 9, p. 1402, doi. 10.1111/j.1464-410X.2011.10163.x
- By:
- Publication type:
- Article
Impact of PSA testing on secondary care costs in England and Wales: estimates from the Cluster randomised triAl of PSA testing for Prostate cancer (CAP).
- Published in:
- BMC Health Services Research, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12913-023-09503-7
- By:
- Publication type:
- Article
Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Investigating the prostate specific antigen, body mass index and age relationship: is an age-BMI-adjusted PSA model clinically useful?
- Published in:
- 2016
- By:
- Publication type:
- journal article
Screening asymptomatic men for prostate cancer: A comparison of international guidelines on prostate-specific antigen testing.
- Published in:
- Journal of Medical Screening, 2022, v. 29, n. 4, p. 268, doi. 10.1177/09691413221119238
- By:
- Publication type:
- Article
PSA Screening and Prostate Cancer Mortality—Reply.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, v. 332, n. 10, p. 843, doi. 10.1001/jama.2024.13809
- By:
- Publication type:
- Article
Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality: A Secondary Analysis of the CAP Randomized Clinical Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, v. 331, n. 17, p. 1460, doi. 10.1001/jama.2024.4011
- By:
- Publication type:
- Article
Antagonistic Gcn5-Hda1 interactions revealed by mutations to the Anaphase Promoting Complex in yeast.
- Published in:
- Cell Division, 2011, v. 6, n. 1, p. 13, doi. 10.1186/1747-1028-6-13
- By:
- Publication type:
- Article
Contemporary accuracy of death certificates for coding prostate cancer as a cause of death: Is reliance on death certification good enough? A comparison with blinded review by an independent cause of death evaluation committee.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Standardisation of information submitted to an endpoint committee for cause of death assignment in a cancer screening trial – lessons learnt from CAP (Cluster randomised triAl of PSA testing for Prostate cancer).
- Published in:
- 2015
- By:
- Publication type:
- journal article
Standardisation of information submitted to an endpoint committee for cause of death assignment in a cancer screening trial - lessons learnt from CAP (Cluster randomised triAl of PSA testing for Prostate cancer).
- Published in:
- BMC Medical Research Methodology, 2015, v. 15, p. 88, doi. 10.1186/1471-2288-15-6
- By:
- Publication type:
- Article
"Let's get the best quality research we can": public awareness and acceptance of consent to use existing data in health research: a systematic review and qualitative study.
- Published in:
- BMC Medical Research Methodology, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2288-13-72
- By:
- Publication type:
- Article
"Let's get the best quality research we can": public awareness and acceptance of consent to use existing data in health research: a systematic review and qualitative study.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study).
- Published in:
- BJU International, 2022, v. 130, n. 3, p. 370, doi. 10.1111/bju.15739
- By:
- Publication type:
- Article
The ProtecT trial: analysis of the patient cohort, baseline risk stratification and disease progression.
- Published in:
- BJU International, 2020, v. 125, n. 4, p. 506, doi. 10.1111/bju.14987
- By:
- Publication type:
- Article
Cost-Effectiveness Analysis of Prostate Cancer Screening in the UK: A Decision Model Analysis Based on the CAP Trial.
- Published in:
- PharmacoEconomics, 2022, v. 40, n. 12, p. 1207, doi. 10.1007/s40273-022-01191-1
- By:
- Publication type:
- Article
Association of diabetes mellitus with prostate cancer: Nested case-control study (Prostate testing for cancer and Treatment study).
- Published in:
- International Journal of Cancer, 2011, v. 128, n. 2, p. 440, doi. 10.1002/ijc.25360
- By:
- Publication type:
- Article
Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality: The CAP Randomized Clinical Trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The ProtecT randomised trial cost-effectiveness analysis comparing active monitoring, surgery, or radiotherapy for prostate cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Standardisation of information submitted to an endpoint committee for cause of death assignment in a cancer screening trial - lessons learnt from CAP (Cluster randomised triAl of PSA testing for Prostate cancer).
- Published in:
- BMC Medical Research Methodology, 2015, v. 15, p. 1, doi. 10.1186/1471-2288-15-6
- By:
- Publication type:
- Article
Characteristics of men responding to an invitation to undergo testing for prostate cancer as part of a randomised trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Characteristics of men responding to an invitation to undergo testing for prostate cancer as part of a randomised trial.
- Published in:
- Trials, 2016, v. 11, p. 1, doi. 10.1186/s13063-016-1624-6
- By:
- Publication type:
- Article